Literature DB >> 15208663

Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas.

Hyunki Kim1, Suk Woo Nam, Hwanseok Rhee, Long Shan Li, Hyun Ju Kang, Kwi Hye Koh, Nam Kyu Kim, Jaehwi Song, Edison Tak-Bun Liu, Hoguen Kim.   

Abstract

Recent molecular genetic studies have revealed that two major types of genomic instabilities, chromosomal instability (CIN) and microsatellite instability (MSI), exist in colorectal carcinomas. In order to clarify the molecular signature related to the CIN and MSI in colorectal carcinomas, we performed transcriptomic expression analysis on eight microsatellite instability-high (MSI-H) colorectal carcinomas and compared the results obtained with that of nine microsatellite stable (MSS) colorectal carcinomas using oligonucleotide microarrays containing 17 334 known genes and 1331 unknown genes or expression sequence tags (ESTs). Unsupervised two-way hierarchical clustering with 5724 genes successfully classified tumors from normal mucosa, and displayed a distinctive MSI-H carcinomas subgroup. Based on intensive filtering, 57 known genes and eight ESTs were found to be highly relevant to the differentiation of MSI-H and MSS colorectal carcinomas. These genes successfully distinguish the new test set of six MSI-H and five MSS colorectal carcinomas. Many up- and downregulated genes in MSI-H colorectal carcinomas were related to the previously reported phenotypic characteristics; increased mucin production and intense peritumoral immune response in MSI-H carcinomas. Some of these differences were confirmed by semiquantitative reverse transcription-PCR and immunohistochemical analysis. Our findings indicate that there are many different genetic and transcriptomic characteristics between MSI-H and MSS colorectal carcinomas, and some of these differently expressed genes can be used as diagnostic or prognostic markers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208663     DOI: 10.1038/sj.onc.1207853

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Gene expression variations in microsatellite stable and unstable colon cancer cells.

Authors:  Marjun P Duldulao; Wendy Lee; Maithao Le; Zhenbin Chen; Wenyan Li; Jinhui Wang; Harry Gao; Haiquing Li; Joseph Kim; Julio Garcia-Aguilar
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

2.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

Review 3.  Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others.

Authors:  Manojkumar Bupathi; Christina Wu
Journal:  J Gastrointest Oncol       Date:  2016-10

Review 4.  Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer.

Authors:  Hiroyuki Yamamoto; Yasushi Adachi; Hiroaki Taniguchi; Hiroaki Kunimoto; Katsuhiko Nosho; Hiromu Suzuki; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

5.  Gene expression differences between colon and rectum tumors.

Authors:  Rebeca Sanz-Pamplona; David Cordero; Antonio Berenguer; Flavio Lejbkowicz; Hedy Rennert; Ramon Salazar; Sebastiano Biondo; Xavier Sanjuan; Miguel A Pujana; Laura Rozek; Thomas J Giordano; Ofer Ben-Izhak; Hector I Cohen; Philip Trougouboff; Jacob Bejhar; Yanina Sova; Gad Rennert; Stephen B Gruber; Victor Moreno
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

6.  mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.

Authors:  Bianca Mostert; Anieta M Sieuwerts; Joan Bolt-de Vries; Jaco Kraan; Zarina Lalmahomed; Anne van Galen; Petra van der Spoel; Vanja de Weerd; Raquel Ramírez-Moreno; Marcel Smid; Cornelis Verhoef; Jan N M IJzermans; Jan W Gratama; Stefan Sleijfer; John A Foekens; John W M Martens
Journal:  Mol Oncol       Date:  2015-01-21       Impact factor: 6.603

7.  Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro.

Authors:  Karin Birkenkamp-Demtroder; Francisco Mansilla; Flemming Brandt Sørensen; Mogens Kruhøffer; Teresa Cabezón; Lise Lotte Christensen; Lauri A Aaltonen; Hein W Verspaget; Torben Falck Ørntoft
Journal:  Mol Oncol       Date:  2007-06-03       Impact factor: 6.603

Review 8.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

9.  Expression profiling of archival tumors for long-term health studies.

Authors:  Levi Waldron; Shuji Ogino; Yujin Hoshida; Kaori Shima; Amy E McCart Reed; Peter T Simpson; Yoshifumi Baba; Katsuhiko Nosho; Nicola Segata; Ana Cristina Vargas; Margaret C Cummings; Sunil R Lakhani; Gregory J Kirkner; Edward Giovannucci; John Quackenbush; Todd R Golub; Charles S Fuchs; Giovanni Parmigiani; Curtis Huttenhower
Journal:  Clin Cancer Res       Date:  2012-11-07       Impact factor: 12.531

10.  Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines.

Authors:  Julia Eschenbrenner; Sebastian Winsel; Stefanie Hammer; Anette Sommer; Kevin Mittelstaedt; Michael Drosch; Ulrich Klar; Christoph Sachse; Michael Hannus; Monika Seidel; Bertram Weiss; Claudia Merz; Gerhard Siemeister; Jens Hoffmann
Journal:  Front Oncol       Date:  2011-11-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.